Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hisashi Higuchi

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Depression and Anxiety|May 11, 2005
A three-factor model of the MADRS in major depressive disorderAkihito Suzuki, Toshiaki Aoshima, Takashi Fukasawa, et al.
American Journal of Medical Genetics|September 5, 2002
Tardive dystonia and genetic polymorphisms of cytochrome P4502D6 and dopamine D2 and D3 receptors: a preliminary findingKazuo Mihara, Tsuyoshi Kondo, Hisashi Higuchi, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|August 21, 2003
Effectiveness of switching to quetiapine for neuroleptic-induced amenorrheaHitoshi Takahashi, Hisashi Higuchi, Mitsuhiro Kamata, et al.
Psychiatry and Clinical Neurosciences|April 17, 2008
No predictors of antidepressant patient response to milnacipran were obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale in Japanese patients with major depressive disordersHisashi Higuchi, Kazuhiro Sato, Keizo Yoshida, et al.
Psychiatry and Clinical Neurosciences|July 1, 2008
Predictors of antidepressant response to fluvoxamine obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale for major depressive disorders in Japanese patientsHisashi Higuchi, Kazuhiro Sato, Keizo Yoshida, et al.
Clinical Neuropharmacology|March 7, 2006
Response rate obtained using milnacipran depending on the severity of depression in the treatment of major depressive patientsYuka Sugawara, Hisashi Higuchi, Keizo Yoshida, et al.
Biological & Pharmaceutical Bulletin|October 6, 2007
No association of the G1287A polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a Japanese populationKazuyuki Inoue, Kunihiko Itoh, Keizo Yoshida, et al.
Journal of Psychopharmacology (Oxford, England)|November 10, 2006
The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamineKeizo Yoshida, Hisashi Higuchi, Mitsuhiro Kamata, et al.
Psychiatry and Clinical Neurosciences|July 6, 2007
Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patientsShingo Naito, Kazuhiro Sato, Keizo Yoshida, et al.
Human Psychopharmacology|October 31, 2002
Remarkable effect of milnacipran in the treatment of Japanese major depressive patientsHisashi Higuchi, Keizo Yoshida, Hitoshi Takahashi, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Depression and Anxiety|May 11, 2005
A three-factor model of the MADRS in major depressive disorderAkihito Suzuki, Toshiaki Aoshima, Takashi Fukasawa, et al.
American Journal of Medical Genetics|September 5, 2002
Tardive dystonia and genetic polymorphisms of cytochrome P4502D6 and dopamine D2 and D3 receptors: a preliminary findingKazuo Mihara, Tsuyoshi Kondo, Hisashi Higuchi, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|August 21, 2003
Effectiveness of switching to quetiapine for neuroleptic-induced amenorrheaHitoshi Takahashi, Hisashi Higuchi, Mitsuhiro Kamata, et al.
Psychiatry and Clinical Neurosciences|April 17, 2008
No predictors of antidepressant patient response to milnacipran were obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale in Japanese patients with major depressive disordersHisashi Higuchi, Kazuhiro Sato, Keizo Yoshida, et al.
Psychiatry and Clinical Neurosciences|July 1, 2008
Predictors of antidepressant response to fluvoxamine obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale for major depressive disorders in Japanese patientsHisashi Higuchi, Kazuhiro Sato, Keizo Yoshida, et al.
Clinical Neuropharmacology|March 7, 2006
Response rate obtained using milnacipran depending on the severity of depression in the treatment of major depressive patientsYuka Sugawara, Hisashi Higuchi, Keizo Yoshida, et al.
Biological & Pharmaceutical Bulletin|October 6, 2007
No association of the G1287A polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a Japanese populationKazuyuki Inoue, Kunihiko Itoh, Keizo Yoshida, et al.
Journal of Psychopharmacology (Oxford, England)|November 10, 2006
The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamineKeizo Yoshida, Hisashi Higuchi, Mitsuhiro Kamata, et al.
Psychiatry and Clinical Neurosciences|July 6, 2007
Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patientsShingo Naito, Kazuhiro Sato, Keizo Yoshida, et al.
Human Psychopharmacology|October 31, 2002
Remarkable effect of milnacipran in the treatment of Japanese major depressive patientsHisashi Higuchi, Keizo Yoshida, Hitoshi Takahashi, et al.
Pageof 6